BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21081044)

  • 1. [Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer].
    Wang Z; Yang K; Wang X; Zhang J; Hao D; Chen Z
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1041-5. PubMed ID: 21081044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.
    Sussan TE; Pletcher MT; Murakami Y; Reeves RH
    Mol Cancer; 2005 Aug; 4():28. PubMed ID: 16083501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of tumor suppressor in lung cancer 1 (TSLC1) binding to differentially expressed in adenocarcinoma of the lung (DAL-1/4.1B).
    Busam RD; Thorsell AG; Flores A; Hammarström M; Persson C; Öbrink B; Hallberg BM
    J Biol Chem; 2011 Feb; 286(6):4511-6. PubMed ID: 21131357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
    Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
    Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
    Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
    Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RA175, which is the mouse ortholog of TSLC1, a tumor suppressor gene in human lung cancer, is a cell adhesion molecule.
    Fujita E; Soyama A; Momoi T
    Exp Cell Res; 2003 Jul; 287(1):57-66. PubMed ID: 12799182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor in lung cancer-1 as a novel ameloblast adhesion molecule and its downregulation in ameloblastoma.
    Usami Y; Ito A; Ohnuma K; Fuku T; Komori T; Yokozaki H
    Pathol Int; 2007 Feb; 57(2):68-75. PubMed ID: 17300670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma.
    Ito A; Okada M; Uchino K; Wakayama T; Koma Y; Iseki S; Tsubota N; Okita Y; Kitamura Y
    Lab Invest; 2003 Aug; 83(8):1175-83. PubMed ID: 12920246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.
    Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y
    Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer.
    Yageta M; Kuramochi M; Masuda M; Fukami T; Fukuhara H; Maruyama T; Shibuya M; Murakami Y
    Cancer Res; 2002 Sep; 62(18):5129-33. PubMed ID: 12234973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
    Houshmandi SS; Surace EI; Zhang HB; Fuller GN; Gutmann DH
    Neurology; 2006 Nov; 67(10):1863-6. PubMed ID: 17130425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
    Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y
    Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
    Ming S; Gao J; Sun T
    Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer.
    Zhang J; Ning J; Geng J; Cui B; Dong X
    J Mol Histol; 2012 Dec; 43(6):715-21. PubMed ID: 22851235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.
    Lu B; Di W; Wang H; Ma H; Li J; Zhang Q
    Tumour Biol; 2012 Dec; 33(6):2007-17. PubMed ID: 23136087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispensable role of protein 4.1B/DAL-1 in rodent adrenal medulla regarding generation of pheochromocytoma and plasmalemmal localization of TSLC1.
    Ohno N; Terada N; Komada M; Saitoh S; Costantini F; Pace V; Germann PG; Weber K; Yamakawa H; Ohara O; Ohno S
    Biochim Biophys Acta; 2009 Mar; 1793(3):506-15. PubMed ID: 19321127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.